Moreover, previous studies have identified CDC45 as a proliferation-associated antigen and have shown its close association with the progression of various cancers, including cervical cancer [40], colorectal cancer [20], acute myeloid leukemia [41]], and ovarian cancer [42]. Here, CDC45 is linked to colorectal cancer.